MuSheng Technology
AI-Powered Hemodialysis Monitoring & Risk Prediction
Integrating dialysis data, hospital information systems, and AI-assisted risk analysis to support real-time clinical monitoring and decision-making.
Presented by:Mu-Sheng Technology × a leading medical center team
This AI Hemodialysis solution is presented by MuSheng Technology. MuSheng Technology and Muen are affiliated companies; this page is hosted on Muen's website.
This AI Hemodialysis solution is presented by MuSheng Technology. MuSheng Technology and Muen are affiliated companies; this page is hosted on Muen's website.
FIVE-STEP FLOWCHART

Dialysis Records → Data Integration → AI Analysis → Abnormal Alerts → AI Recommendations
THREE CORE VALUES
Real-time Monitoring
Monitor dialysis parameters and patient status throughout treatment.
Data Integration
Integrate dialysis machines, HIS, LIS, PACS, and standardized FHIR data across systems.
AI Risk Prediction
Analyze dialysis data and provide AI-assisted heart failure risk alerts for clinical attention.
Real-Time Multi-Patient Monitoring
Monitor dialysis status across multiple patients and identify potential risk levels at a glance.

Color-coded risk levels (Normal / HF / IDH) help clinicians spot cases needing attention.

Live feed of a single patient
Real-World Clinical Evidence
The heart-failure prediction and dry-weight prediction models were validated over two years across three dialysis units of a leading medical center in Northern Taiwan. Before vs. after deployment:
5.94% → 3.93%
Mortality rate
14.87% → 7.45%
One-year mortality
5.40% → 4.23%
CHF-related mortality
79.31% → 45%
Cardiopulmonary-system mortality
Heart Failure Risk Model Performance
Model evaluation metrics based on the current heart failure risk prediction model.


| Metrics | Model |
|---|---|
| Sensitivity | 0.833 |
| Specificity | 0.947 |
| PPV | 0.857 |
| NPV | 0.937 |
| F1 score | 0.845 |
| AUC | 0.809 |
Want to learn more about the AI Hemodialysis solution?
Contact us to learn how real-time monitoring, data integration, and AI-assisted risk analysis can be applied.
Contact Us
Name/Company/Title/Email/Country, Projects of Interest (Product Showcase/Cooperation Negotiation/Hospital Integration/Other), Message
展出單位(方案提供):沐盛科技 × 北部醫學中心團隊
本 AI 血液透析方案由沐盛科技展出;沐盛科技與沐恩為關係企業,本方案頁面建置於沐恩網站。